GB2057447A - Microbial Process for Producing Cholanic Acid Derivatives and Microbes used Therein - Google Patents
Microbial Process for Producing Cholanic Acid Derivatives and Microbes used Therein Download PDFInfo
- Publication number
- GB2057447A GB2057447A GB8024436A GB8024436A GB2057447A GB 2057447 A GB2057447 A GB 2057447A GB 8024436 A GB8024436 A GB 8024436A GB 8024436 A GB8024436 A GB 8024436A GB 2057447 A GB2057447 A GB 2057447A
- Authority
- GB
- United Kingdom
- Prior art keywords
- strain
- atcc
- ferm
- arthrobacter
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/02—Dehydrogenating; Dehydroxylating
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/06—Arthrobacter
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/13—Brevibacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
A microbial process for producing a cholanic acid derivative of the formula: <IMAGE> wherein X is <IMAGE> or =O; and R is hydrogen, an alkali metal or an alkaline earth metal, comprises cultivating a microbe which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce the cholanic acid derivative, selected from the genera Arthrobacter, Brevibacterium and Corynebacterium, in a culture medium containing the substrate and collecting the resulting derivative. The invention also includes several new species of microorganisms.
Description
SPECIFICATION
Microbial Process for Producing Cholanic Acid Derivatives and Microbes Used Therein
The present invention relates to a microbial process for producing a cholanic acid derivative of the formula:
wherein X is
or =0; and R is hydrogen, an alkali metal or an alkaline earth metal and to microbes used in the process. More particularly, according to the present invention, the cholanic acid derivatives of the formula (I) can be produced in a high yield within a short period by cultivating a specific microbe in a culture medium containing cholic acid or a salt thereof as a substrate.
The cholanic acid derivative of the formula (I) wherein Xis
namely,3a,7a-dihydroxy-12-keto-5p-cholanic acid or a salt thereof is a useful intermediate for producing a gallstones solubilizer, chenodeoxycholic acid (CDCA). The cholanic acid derivative of the formula (I) wherein X is =0, namely,7ce-hydroxy-3,12-diketo-5p-cholanic acid or a salt thereof is a useful intermediate for producing deoxycholic acid which is a useful starting material in the production of progesterone and adrenal corticosteroid derivatives.
It has hitherto been known that the cholanic acid derivatives of the formula (I) can be obtained by a microbial process using cholic acid or a salt thereof as a substrate. For example, Hayakawa et al.
disclose a process for producing 3a,7a-dihydroxy-1 2-keto-5,l-cholanic acid by using Streptomyces gelaticus 1 164 strain [The Journal of Biochemistry (Japan), Viol. 44, No. 2, pages 109 to 113 (1957); and Proceedings of Japan Academy, Vol. 32, pages 519 to 522 (1956)]. Hasegawa et al. disclose a process for producing 3a,7a-dihydroxy-12-keto-5p-cholanic acid by using Aspergillus cinnamomeus
HUT 2026 strain [Hiroshima Journal of Medical Science, Vol. 8, No, 3, pages 277 to 283 (1959)].
Kikuchi et al. also disclose a process for producing 3cg,7-dihydroxy-12-keto-5p-cholanic acid by using
Staphylococcus epidermidis H-1 strain [Journal of Biochemistry, Vol. 72, No. 1, pages 1 65 to 172 (1972)]. Further, Hayakawa et al. disclose a process for producing 7a-hydrnxy-3,12-diketo-5,l- cholanic acid by using Streptomyces gelaticus 1164 strain [Proceedings of Japan Academy, Vol. 32, pages 519 to 522 (1956)].
However, in these processes, a concentration of cholic acid as a substrate in a culture medium is low, such as not more than 10 g/l. According to the present inventors' experiment, it is necessitated to use cholic acid in a low concentration in the production of the cholanic acid derivatives by the known microbial processes since the microbes to be used are undergrown or hardly grow when a concentration of cholic acid in a culture medium is as high as not less than 20 g/l. Moreover, these known processes require too much period of time for the cultivation. Therefore, it has been desired to develop a process for producing the cholanic acid derivatives in a high yield within a short period of time.It has now been found that certain microbes belonging to the genera Arthrobacter,
Brevibacterium and Corynebacterium can grow in a medium containing cholic acid or its salt as a substrate in a concentration ranging widely and can produce the cholanic acid derivatives in a high yield within a short period of time.
One object of the present invention is to provide a microbial process for producing the cholanic acid derivatives of the formula (I) in a high yield within a short period of time. Another object of the present invention is to provide novel microbes which are capable of growing in a medium containing cholic acid or a salt thereof as a substrate. These objects as well as other objects and advantages of the present invention will become apparent to those skilled in the art from the following description.
According to the present invention, there is provided a microbial process for producing a cholanic acid derivative of the formula (I) which comprises cultivating a microbe which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce the cholanic acid derivative, selected from the genera Arthrobacter, Brevibacterium and Corynebacterium, in a culture medium containing the substrate and collecting the resulting derivative.
Microbes to be used in the present invention are those isolated from soil and mutants thereof obtained by natural mutation, or produced by, for example, X-ray irradiation, ultraviolet irradiation, a
mutating agent such as N-methyl-Nt-nitro-N-nitroso guanidine, 4-nitroquinoline-N-oxide, acriflavine or ethyl methane sulfonate or combination thereof and the like.
Among the microbes being capable of producing the cholanic acid derivative of the formula (I) in a culture medium containing oholic acid or its salt obtained by the present inventor, the representatives are deposited with Fermentation Research Institute, Agency of Industrial Science and Technology,
Japan (hereinafter, referred to as FERM) and with American Type Culture Collection, U.S.A.
(hereinafter, referred to as ATCC). They are Arthrobacter CA-35 strain (FERM-P No. 5145; ATCC No.
31651), Arthrobacter CA-35A589-29-32 strain (FERM-P No.5522; ATCC No. 31652),Arthrobacter
CA-35-A589-47 strain (FERM-P No. 55,23;ATCC No. 31653),ArthrobacterCA-35-A849 strain (FERM-P No. 5524; ATCC No. 31654), Arthrobacter CA-35-A-1071-15 strain (FERM-P No. 5525;
ATCC No. 31655), Arthrobacter CA-35-A-1448 strain (FERM-P No. 5526; ATCC No. 31656), Arthrobacter CA-3 5-A-1 47 5 strain (FERM-P No. 5527; ATCC No. 31 657), Arthrobacter CA-3 5-A
1766-15 strain (FERM-P No. 5528;ATCC No, 31658), Arthrobacter CA-35-M-965-3 strain (FERM-P No. 5529; ATCC No. 31659), Arthrobacter CA-35-Y-37-1 2 strain (FERM-P No. 5530;; ATCC No.
31660), Brevibacterium CA-6 strain (FERM-P No. 5144; ATCC No. 31661) and Corynebacterium CA53 strain (FERM-P No. 5532; ATCC No. 31 662).ArthrobacterCA-35, Brevibacterium CA-6 and
Corynebacterium CA-53 strains are wild type strains and the other nine Arthrobacter strains are mutants of Arthrobacter CA-35 strain. Arthrobacter CA-35-Y-37-1 2 strain is produced by ultraviolet irradiation. The other eight mutants of Arthrobacter CA-35 strain are obtained by treatment of the parent strain with N-methyl-N'-nitro-N-nitrosoguanidine.
The morphological, cultural and physiological characteristics of these strains are set forth in Table
1. For comparison, these characteristics ofArthrobacter simplex IAM 1 660 strain which has a relation toArthrobacter CA-35 strain are also shown in Table 1.
Table 1
Arthrobacter simplex Arthrobacter CA-35
Characteristics IAM 1660 Strain Strain
Microscopic observation
Form rods (sometimes swollen or curved) rods (sometimes snapped or curved)
Division snapping
Size (,u) 0.4-0.5x 1-3 0.8-0.9x 1.7-2.2 Flagellum none none
Spore none none
Gram stain positive-variable positive
Acid fast stain none none Cultural observation
Bouillon agar plate circular, slightly raised, circular, slightly raised, yellow to
colorless, smooth, glistening, cream-colored, smooth, glistening
transparent opaque
Gelatin stab saccate liquefaction no liquefaction
Litmus milk litmus reduced, milk cleared litmus reduced, milk unchanged
BCP milk clearing, becoming alkaline alkaline, not coagulated and not
peptonized
Physiological character
Nitrate reduction + +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production H2S production + +
Starch hydrolysis
Citrate utilization + +
Assimilation of inorganic + +
nitrogen sources
Urease
Oxidase - #to- Catalase + +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative
test
Production of acids and gases from carbohydrates2) growth acids gases assimilation growth acids gases assimilation
1. L-arabinose + - - - # - - +++
2. D-xylose + - - - + - - # to
3. D-glucose + - - ++ + + - +++
4.D-mannose + - - - + - - ++
5.D-fructose + - - + + + - ++
6. D-galactose + - - - + - - ++
7. Maltose + - - + + - - ++
8. Sucrose + - - # + - - # 9. Lactose + - - - + - - 10. Trehalose + - - + + - - -
11. D-sorbitol + - - - + - -
12. D-mannitol + - - - + - -
13. Inositol + - - - + - -
14. Glycerol + - - - + - - ++
15.Starch + - - - + - -
Table 1 (Continued)
Arthrobacter CA-35-A589- Arthrobacter CA-35-A589
Characteristics 29-32 Strain 47 Strain
Microscopic observation
Form short rod short rod
Division
Size (,u) 0.8-1 Ox 1.3-2.0 0.8-1 Ox 1.3-2.3 Flagellum polar flagellum flagellum
Spore none none
Gram stain positive positive
Acid fast stain none none
Cultural observation
Bouillon agar plate circular, flat, yellow, smooth, circular, flat, yellow, smooth,
glistening, opaque glistening, opaque
Bouillon agar circular, flat, yellow, smooth, circular, flat, white to pale cream
plate containing glistening, opaque colored, smooth, glistening,
cholic acid opaque
(10 g/l)
Gelatin stab liquefaction liquefaction
Litmus milk litmus reduced, milk not litmus reduced, milk not
coagulated and not peptonized coagulated and not peptonized
BCP milk alkaline, not coagulated and alkaline, not coagulated and
not peptonized not peptonized
Physiological character')
Nitrate reduction + +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production
H2S production + +
Starch hydrolysis
Citrate utilization + +
Assimilation of inorganic
nitrogen sources
ammonium + +
nitrate + +
Urease
Oxidase
Catalase + +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative
test
Production of acids and gases from carbohydrates acids gases acids gases
1. L-arabinose + - +
2. D-xylose - - 3. D-glucose + - -
4. D-mannose -
5. D-fructose + - +
6. D-galactose -
7. Maltose + - + -
8. Sucrose -
9. Lactose
10. Trehalose -
11.D-sorbitol - - 12. D-mannitol - - 13.lnositol -
14. Glycerol -
15. Starch - - Table 1 (Continued)
Arthrobacter CA-35- Arthrobacter CA-35-A
Characteristics A849 Strain 1071-15 Strain
Microscopic observation
Form short rod short rod
Division
Size ( ) 0.7-1 Ox 1.3-2.3 0.8-1 Ox 1.3-2.5 Flagellum none none
Spore none none
Gram stain positive positive
Acid fast stain none none
Cultural observation
Bouillon agar plate circular, flat, yellow, smooth, circular, flat, yellow, smooth,
glistening, opaque glistening, opaque
Bouillon agar circular, flat, white to pale circular, flat, white to pale cream
plate containing cream-colored, smooth, glistening, colored, smooth, glistening,
cholic acid opaque opaque
(10 g/l)
Gelatin stab liquefaction liquefaction
Litmus milk litmus reduced, milk not litmus reduced, milk not
coagulated and not peptonized coagulated and not peptonized
BCP milk alkaline, not coagulated and alkaline, not coagulated and
not peptonized not peptonized
Physiological character1
Nitrate reduction + +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production
H2S production + +
Starch hydrolysis
Citrate utilization + +
Assimilation of inorganic
nitrogen sources
ammonium + +
nitrate + +
Urease
Oxidase
Catalase + +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative oxidative
test
Production of acids and
gases from carbohydrates) acids gases acids gases
1. L-arabinose - - + 2. D-xylose - - -
3. D-glucose + - +
4.D-mannose - - - - 5. D-fructose + - +
6. D-galactose - - +
7. Maltose + - +
8. Sucrose
9. Lactose
10. Trehalose - - -
11.D-sorbitol - - - - 12. D-mannitol - - - 1 3. Inositol
14. Glycerol + - +
15.Starch
Table 1 (Continued)
Arthrobacter CA-35- Arthrobacter CA-35
Characteristics A-1448 Strain A-1475 Strain
Microscopic observation
Form short rod short rod to coccus
Division
Size ( ) 0.7-1.0x1.2-2.0 1.0-1.3x1.2-1.8
Flagellum flagellum flagellum
Spore none none
Gram stain positive positive
Acid fast stain none none
Cultural observation
Bouillon agar plate circular, flat, yellow, smooth, circular, flat, yellow, smooth,
glistening, opaque glistening, opaque
Bouillon agar circular, flat, white to pale circular, flat, white to pale cream-.
plate containing cream-colored, smooth, glistening, colored, smooth, glistening,
cholic acid opaque opaque
(10 g/l)
Gelatin stab liquefaction liquefaction
Litmus milk litmus reduced, milk not litmus reduced, milk not
coagulated and not peptonized coagulated and not peptonized
BCP milk alkaline, not coagulated and alkaline, not coagulated and
not peptonized not peptonized
Physiological character"
Nitrate reduction + +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production
H2S production + +
Starch hydrolysis
Citrate utilization + +
Assimilation of inorganic
nitrogen sources
ammonium + +
nitrate + +
Urease
Oxidase
Catalase +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative
test
Production of acids and gases from carbohydrate2) acids gases acids gases 1.L-arabinose + - - - 2. D-xylose - - - - 3. D-glucose + - -
4. D-mannose - - - - 5. D-fructose + - +
6. D-galactose
7. Maltose + - -
8. Sucrose
9. Lactose
10. Trehalose - - - 11. D-sorbitol - - - - 12. D-mannitol - - 13.lnsitoI -
14. Glycerol + - - - 15.Starch
Table 1 (Continued)
Arthrobacter CA-35-A- Arthrobacter CA-35-M
Characteristics 1766-15 Strain 965-3 Strain
Microscopic observation
Form short rod short rod to coccus
Division
Size ( ) 0.6-1.2x1.0-2.3 1.0-1.2x0.8-1.6
Flagellum flagellum flagellum
Spore none none
Gram stain positive positive
Acid fast stain none none
Cultural observation
Bouillon agar plate circular, flat, yellow, smooth, circular, flat, yellow, smooth,
glistening, opaque glistening, opaque
Bouillon agar plate circular, flat, yellow, smooth, circular, flat, white to cream
containing cholic glistening, opaque colored, smooth, glistening, acid (10 g/l) opaque
Gelatin stab liquefaction no liquefaction
Litmus milk litmus reduced, milk not litmus reduced, milk not
coagulated and not peptonized coagulated and not peptonized
BCP milk alkaline, not coagulated and alkaline, not coagulated and
not peptonized not peptonized
Physiological character1
Nitrate reduction + +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production
H2S production + +
Starch hydrolysis
Citrate utilization + +
Assimilation of inorganic
nitrogen sources
ammonium + +
nitrate +
Urease
Oxidase
Catalase + +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative oxidative
test
Production of acids and gases from carbohydrates2) acids gases acids gases
1. L-arabinose - - +
2. D-xylose - - - - 3. D-glucose + - + 4. D-mannose - - - - 5. D-fructose + - +
6. D-galactose - - - - 7. Maltose + - +
8. Sucrose
9. Lactose
10. Trehalose - - -
11.D-sorbitol - - - - 12. D-mannitol - - - - 13.Inositol - - -
14. Glycerol + - - - 15. Starch - - -
Table 1 (Continued) Arthrobacter CA -35- Y- Brevibacterium
Characteristics 37-12 Strain CA-6 Strain
Microscopic observation
Form short rod rod
Division
Size ( ) 0.8-1.0x1.5-2.5 1.0x2.5-4.0
Flagellum flagellum polar flagellum
Spore none none
Gram stain positive positive
Acid fast stain none none
Cultural observation
Bouillon agar plate circular, flat, yellow, smooth, undulate, slightly raised,
glistening, opaque colorless, smooth, glistening,
translucent
Bouillon agar plate circular, flat, cream-colored,
containing cholic smooth, glistening, opaque
acid (10g/l)
Gelatin stab liquefaction liquefaction
Litmus milk litmus reduced, milk not peptonized and becoming alkaline
coagulated and not peptonized
BCP milk alkaline, not coagulated and peptonized and becoming alkaline
not peptonized
Physiological character)
Nitrate reduction +
Denitrification - +
Methyl red test
Voges-Proskauer test
Indole production
H2S production + +
Starch hydrolysis - +
Citrate utilization + +
Assimilation of inorganic +
nitrogen sources
ammonium +
nitrate +
Urease
Oxidase - # Catalase + +
Require of oxygen aerobic aerobic
Oxidation/Fermentation oxidative
test
Production of acids and gases from carbohydrates2) acids gases growth acids gases assimilation
1. L-arabinose + - + + - 2. D-xylose - - + + - # 3. D-glucose + - + + - ++
4.D-mannose - - + + - +
5. D-fructose + - + + - +++ 6. D-galactose - - + # - ++ 7- Maltose + - + - - ++
8. Sucrose - - + - -
9. Lactose - - + - -
10. Trehalose - - + - - # 11. D-sorbitol - - + - -
12. D-mannitol - - + - -
13. Inositol + - + - - ++
14. Glycerol + - + +
15.Starch - - + - -
Table 1 (Continued) Characteristics Coryneba cterium CA -53 Strain
Microscopic observation
Form rod, coryneform
Division snapping
Size (u) 1.3--2.4x 1.0-1.2 Flagellum none
Spore none
Gram stain positive
Acid fast stain none
Cultural observation
Nutrient agar plate circular, flat, yellow, smooth, glistening,
opaque
Gelatin stab no liquefaction
Litmus milk litmus reduced with brown sediment
BCP milk alkaline
Physiological character') Nitrate reduction +
Denitrification
Methyl red test
Voges-Proskauer test
Indole production
H2S production +
Starch hydrolysis
Citrate utilization +
Assimilation of inorganic
nitrogen sources +
Urease
Oxidase +
Catalase +
Require of oxygen aerobic
Oxidation/Fermentation
test
Production of acids and gases from carbohydrates2) acids gases
1. L-arabinose
2. D-xylose
3. D-glucose
4. D-mannose
5. D-fructose
6. D-galactose
7. Maltose
8. Sucrose
9. Lactose
10. Trehalose
11. D-sorbitol
12. D-mannitol 1 3. Inositol
14.Glycerol 1 5. Starch
Remarks
1) The symbols used in Physiological character mean as follows:
+: The strain has the corresponding character or produces the corresponding product.
+: It is difficult to determine whether the strain has the corresponding character or produces the
corresponding product or not.
-: The strain does not have the corresponding character or does not produce the corresponding
product.
2) The symbols used in Production of acids and gases from carbohydrates mean as follows:
i) growth, acids and gases:
The strain was cultivated in Hugh and Leifson medium provided that each of the
carbohydrates 1 to 1 5 is substituted for the carbon source and the growth thereof and acids
and gases production were observed.
+: The strain grows or a acid or a gas is produced.
+: It is difficult to determine whether the strain grows or a acid or a gas is produced or not.
-: The strain does not grow or a acid or gas is not produced.
ii) assimilation:
The culture medium comprising NH4NO3 (2 g/l), KH2PO4 (2 g/l), K2HPO4 (5 g/l), MgSO4. 7H2O (0.2 g/l), yeast extract (0.1 g/l) and one of the carbohydrates 1 to 15 (5 g/i) was put into a tube (diameter 21 mm), the strain was cultivated with shaking therein and its
assimilation (growth) was observed.
-: The strain does not grow.
+: The strain grows slightly.
+: The strain grows.
++: The strain grows well.
+++: The strain grows very well.
On the basis of these morpholigical, cultural and physiological characteristics, the classification of
the strains has been determined according to Bergey's Mannual of Determinative Bacteriology 7th and
8th Editions.
It is determined that Arthrobacter CA-3 5 strain has a relation to Arthrobacter simplex in view of
its microscopic observation such as form, gram stain and the like as well as its physiological character.
However, Arthrobacter CA-35 strain is different from Arthrobacter simplex IAM 1660 strain in view of
their pigment production, assimilation of carbohydrates and growth in a medium containing colic acid. Arthrobacter CA-35 strain can grow in a medium containing sodium cholate as the sole carbon
source in a high concentration such as about 20 to 500 g/l to produce as main metabolic products 7- hydroxy-3, 1 2-diketo-5p-cholanic acid, 3cg,7 ez-dihydroxy- 1 2-keto-5p-cholanic acid, 7 #t 12 2-dihydrnxy- 3-keto-5p-choianic acid and/or sodium salts thereof whereasArthrobactersimplex IAM 1660 strain
can hardly grow in a medium containing sodium cholate as the sole carbon source in a concentration of 10 g/l.
Arthrobacter CA-35 strain produces yellow to cream-colored pigments. On the other hand, as a
microbe which belongs to the genus Arthrobacter and has a pigment productivity, there exist
Arthrobacter oxydans, Arthrobacter aurescens and Arthrobacter ureafaciens. However, Arthrobacter
CA-35 strain is also different from these microbes since Arthrohacter oxydans and Arthrobacter aurescens are usually gram-negative and hydrolyze starch and Arthrobacter ureafaciens is usually gram-negative and does not reduce a nitrate. Thus, it is believed thatArthrobacter CA-35 strain constitutes a new species belonging to the genus Arthrobacter since it is different from strains of standard species belonging to the genusArthrobacter.
Although some of the mutants of Arthrobacter CA-35 strain are quite different from the parent strain in view of flagella, it is determined that these mutants belong to Arthrobacter since, generally, a mutant is classified into the same species of its parent strain.
It is determined that Brevibacterium CA-6 strain belongs to the genus Brevibacterium in view of its microscopic observation such as gram stain and the like and its physiological character. However,
Brevibacterium CA-6 strain is somewhat different from other microbes belonging to the genus
Brevibacterium since the other microbes have peritrichous flagella whereas Brevibacterium CA-6 strain has polar flagellum and so on.
Further, it is determined that Corynebacterium CA-53 strain has a close relation to
Corynebacterium equi.
The process of the present invention is carried out by cultivating a microbe which is capable of
growing in a medium containing cholic acid or its salt as a substrate, selected from the genera
Arthrobacter, Brevibacterium and Corynebacterium, like the above in a culture medium containing
cholic acid or its salt as a substrate.
In the present invention, cholic acid per se can be used as a substrate. There can be also used an
alkali metal salt of cholic acid such as sodium cholate, potassium cholate or the like or an alkaline earth
metal salt of cholic acid such as calcium cholate, magnesium cholate or the like, preferably an alkali
metal salt. When a cholate is used, it is dissolved in a water to prepare an aqueous solution containing
the cholate in a predetermined concentration. Alternatively, a certain amount of an alkali metal
compound or an alkaline earth metal compound which forms a salt with cholic acid may previously be
dissolved in water and added thereto cholic acid to obtain an aqueous solution containing a cholate in
a predetermined concentration. Concentration of cholic acid or its salt may be varied widely in a range of from about 1 to 500 g/l as cholic acid. In view of a yield of the desired cholanic acid derivatives of the formula (I), conditions for cultivation and economic efficiency such as operability, workability and the like, it is recommended that cholic acid or its salt is used in a concentration of about 5 to 300 g/l, preferably, about 10 to 200 g/l as cholic acid.
Cultivation can be carried out according to a known method and, usually, a shaking or submerged culture using a liquid medium is employed.
As a medium, there can be used one containing nutrients which can be assimilated by a microbe to be used. A medium can contain cholic acid or its salt as the sole carbon source or an additional carbon source such as a pentose (e.g. arabinose etc), a hexose (e.g. glucose, mannose, fructose,
galactose etc), a disaccharide (e.g. maltose etc.), a starch decomposition product (e.g. dextrin etc.), a
sugar alcohol (e.g. sorbitol etc), a polyvalent alcohol (e.g. glycerol etc.), a mixture thereof or the like
and/or another nutrient such as polypeptone, a peptone, meat extract, malt extract, corn steep liquor, yeast extract, an amino acid, a mixture thereof or the like. Usually, an additional carbon source and/or
another nutrient can be added to a medium in a concentration of about 0.1 to 10 g/l.As a nitrogen source, there can be used, for example, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium nitrate, sodium nitrate, potassium nitrate, a mixture thereof and the like.
Usually, a nitrogen source can be added to a medium in a concentration of about 0.5 to 5 g/l. Further, as inorganic salts, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate and the like can be added to a medium, usually, in a concentration of about 0.1 to 10 g/l.
Cultivation can be carried out in a shaking or submerged culture at 25 to 350C for 6 hours to 5 days.
According to the process of the present invention, cholic acid or its salt used as a substrate is converted into the cholanic acid derivatives of the formula (I) and a small amount of 7 a,1 2a-dihydrnxy- 3-keto-5,!3-cholanic acid or its salt when Arthrobacter CA-35 strain is used. It has been found that the cholanic acid derivative of the formula (I) wherein X is
namely, 3a,7a-dihydroxy-1 2-keto-5-cholanic acid or its salt is predominantly produced when the above mutants of Arthrobacter CA-35 are used.Therefore, when 3,r,7a-dihydrnxy-1 2-keto-5- cholanic acid or its salt is desired, it is preferable to use these mutants, especially, Arthrobacter CA-35
A589-29-32 strain (FERM-P No.5522; ATCC No. 31652),ArthrobacterCA-35-A589-47 strain (FERM-P No. 5523;ATCC No.31653), andArthrobacterCA-35-A-1766-15 strain (FERM-P No.5528; ATCC No. 31658). Particularly, Arthrobacter CA-35-A589-29-32 strain and Arthrobacter CA-35
A589-47 strain are more preferable. When Brevibacterium CA-6 strain is used, cholic acid or its salt is converted into the cholanic acid derivatives of the formula (i) and a small amount of 7sw-hydroxy-3,12- diketo-å4-cholenic acid or its salt.When Corynebacterium CA-53 strain is used, cholic acid or its salt is converted into the cholanic acid derivatives of the formula (I) and 7a-hydroxy-3,1 2-diketo-A4-cholenic acid or its salt.
After completion of cultivation, products accumulated in the medium are separated from the medium and purified. Firstly, insoluble materials in the medium such as microbial cells and the like are removed from the medium by a known method such as filtration, centrifugation and the like. Then, a filtrate or supernatant is acidified by addition of an acid such as hydrochloric acid to precipitate products therein. At the same time, cholic acid or its salt used as a substrate which remains without being converted is also precipitated as cholic acid. After separation of the resulting precipitate, the filtrate or supernatant is further extracted with an inert organic solvent such as ethyl acetate or the like and the soivent is distilled off from the extract to obtain a residue. Thereby, remaining products and the substrate are almost completely recovered.The resulting residue is combined with the above obtained precipitate.
A mixture of products and cholic acid thus obtained is subjected to chromatography to isolate the desired product. For example, products obtained by using Arthrobacter CA-35 strain or a mutant thereof can be isolated as follows: Products and cholic acid are converted into methyl esters thereof and the obtained methyl esters are subjected to chromatography on a silica gel column by successively eluting with chloroform, chloroform-ethanol (99:1, v/v) and then chloroform-ethanol (97:3, v/v). The desired 7a-hydraxy-3,1 2-diketo-SP-cholanic acid methyl ester is eluted with chloroform.By elution with chloroform-ethanol (99:1, v/v), firstly, one of the by-prociucts,7a,12cg-dihydroxy-3-keto-5p- cholanic acid methyl ester and then, the desired 3a,7sg, dihydroxy-l 2-keto-SP-cholanic acid methyl ester are eluted. Methyl cholate is eluted with chloroform-ethanol (97:3, v/v). These methyl esters can be converted into the corresponding acids by hydrolysis according to a standard method. Alternatively, when Brevibacterium CA-6 strain or Corynebacterium CA-53 strain is used, products can be isolated, for example, as follows: A mixture of products and cholic acid are directly subjected to chromatography on a silica gel by succesively eluting with chloroform-ethanol (98:2, v/v) and then chloroform-ethanol (97:3, v/v).The desired 7,-hydroxy-3,12-diketo-5ss-cholanic acid is eluted with chloroform-ethanol (98:2, v/v). By elution with chloroform-ethanol (97:3, v/v), firstly, a by-product, 7a-hydroxy-3,12- diketo-A4-cholenic acid is eluted and then, the desired 3a,7-dihydroxy-12-keto-5,B-cholanic acid is eluted.
3a,7 a-dihydroxy-l 2-keto-SP-cholanic acid or its salt obtained by the present invention can be readily reduced according to Huang Minlon reduction method to give a useful gallstones solubilizer, chenodeoxycholic acid (CDCA).
7a-hydrnxy-3,1 2-diketo-5-choIanic acid or its salt can be readily converted into deoxycholic acid, which is a useful starting material in the production of progesterone and adrenal corticosteroid derivatives, by dehydration, followed by hydrogenation according to a standard method.
The following examples and reference examples further illustrate the present invention in detail
but are not to be construed to limit the scope thereof.
Preparation of Mutants
One loopful of Arthrobacter CA-35 strain (FERM No. 5145; ATCC No. 31651) cultivated on a
slant medium (medium A; NaOH 0.5%, cholic acid 5.0%, peptone 0.5%, yeast extract 0.5%, NaCl 0.5%
and agar 1.5%) was inoculated into a medium (10 ml, medium B: NaOH 1%, cholic acid 10%, NH4NO3
0.2%, KH2PO4 0.2%, K2HPO4 0.5%, MgSO4. 7H20 0.02% and yeast extract 0.01%) in a test tube (200 mmx21 mm in diameter), and incubated with shaking at 300C for 24 hours.The resulting culture (0.3
ml) was added to a medium (10 ml, medium C: NaOH 0.05%, cholic acid 0.5%, glucose 0.5%, NH4NO3 0.2% KH2PO4 0.2%, K2HPO4 0.5%, MsSO4 . 7H2O 0.02% and yeast extract 0.01%) in a test tube (200
mx21 mm in diameter) and incubated with shaking at 30 C for 15 hours. The microbial cells
in a log phase were harvested by a membrane filter (pore size 0.45 ) under aseptic conditions, washed
with 0.1 M phosphate buffer (pH 7.0, 20 ml) and suspended in the same buffer (25 ml).
A treatment of mutation was carried out by adding N-methyl-N'-nitro-N-nitrosoguanidine in a
final concentration of 50 l/ml to the above cell suspension (4 ml) in test tube (200 mmx21 mm in
diameter) and incubating the mixture with shaking at 30 C for 45 minutes. Under this condition, ,a
lethal rate of Arthrobacter CA-35 strain was about 80%.
The cells thus treated were harvested by a membrane filter (pore size, 0.45 y) under aseptic
conditions, washed with 0.1 M phosphate buffer (pH 7.0, 20 ml) and suspended in the same buffer (25
ml). The resulting cell suspension was diluted with nstelized normal saline solution and spreaded on
agar plates (medium D:NaOH 0.1%, cholic acid 1.0%, Nh4OH 0.2%, KH2PO4 0.2%, K2HPO4 0.5%,
MgSO4 , 7H2O 0.02%, yeast extract 0.01% and agar 1.5%) so as to form 300 to 500 colonies per one plate. The plates were incubated at 300C for 4 days. Each pin point colony thus formed was isolated and incubated on a plate (medium E: peptone 0.5%, yeast extract 0.5%, NaCI 0.5% and agar 1.5%) at 30 C for 24 hours. Each colony formed on the plate of medium E was replicated on a plate of medium
D and incubated at 30 C for 20 hours.
Each colony on the above plate of medium E, of which replicated colony did not grow on the plate of medium D, was incubated on a slant medium (medium F: NaOH 0.1%, cholic acid 1.0%, peptone 0.5%, yeast extract 0.5%, NaCI 0.5% and agar 1.5%) at 300C for 24 hours. One loopful of this slant culture was inoculated into a medium (10 ml, medium G: NaOH 0.5%, cholic acid 5.0%, glucose 0.5%, NH4NO3 0.2%, KH2PO4 0.2%, K2HPO4 0.5%, MgSO4. 7H20 0.02% and yeast extract 0.01%) in a test tube (200 mmx21 mm in diameter) and incubated with shaking at 300C for 3 days.
Upon examining products accumulated in each medium G by thin layer chromatography, a microbe which selectively produced 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid or its salt was fuond and named Arthrobacter CA-35-M-965-3 strain.
The above mentioned procedure is hereafter referred to as "procedure M". According to the procedure M, a treatment of mutation was carried out by using Arthrobacter CA35-m-965-3 strain as a parent strain. As the result, three strains which selectively produced 3ex,7a:-dihydroxy-12-keto-5,B- cholanic acid or its salt were found and named Arthrobacter CA-3 5-A589, Arthrobacter CA-35-A849 and Arthrobacter CA-35-A-1 071 strains, respectively.
From the colony ofArthrobacterCA-35-A589 strain, two superior strains were isolated and these
strains were named Arthrobacter CA-35-A589-29-32 strain and Arthrobacter CA-35-A589-47 strain,
respectively. One superior strain was also isolated from the colony of Arthrobacter CA-35-A-1 071 strain and named Arthrobacter CA-35-A- 1071 - 1 5 strain.
Further one superior strain was produced by usingArthrobacterCA-35-A849 strain as a parent
strain according to the procedure M and namedArthrobacterCA-35-A-1448 strain. Arthrobacter CA 35-A-1 475 strain was produced by using Arthrobacter CA-35-A-1448 strain as a parent strain
according to the procedure M. Arthrobacter CA-35-A-1 766 strain was produced by using Arthrobacter
CA-35-A-1071 strain as a parent strain according to the procedure M, and Arthrobacter CA-35-A 1766-15 strain was isolated from the colony of the resultingArthrobacterCA-35-A-1 766 strain.
Arthrobacter CA-35-Y-37-12 strain was produced according following procedure.
One loopful of Arthrobacter CA-35 strain (FREM-P no. 5145; ATCC No. 31651) cultivated on a
slant of medium A was inocculated into medium B (10 ml) in a test tube (200 mmx21 mm in diameter)
and incubated with shaking at 300C for 20 hours. Microbial cells were harvested by centrifuging (10,000 rpm) at 50C for 5 minutes under aseptic conditions. The cells were suspended in sterilized water (10 ml). The suspension was put into a Petri dish (diameter 7.5 cm) placed at about 27 cm distant under a 15 W ultraviolet lamp (2537 ) in a germ-free box and irradiated with ultraviolet rays for 10 minutes. Under this condition, a lethal rate ofArthrobacter CA-35 strain was about 99.9%.
After irradiation, the microbial cells were harvested by a membrane filter, washed with 0.1 M phosphate buffer and suspended in the same buffer. The resulting suspension was diluted with a normal saline solution and the above cultivation using media D to G was repeated to obtain a superior strain which selectively produced 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid ot its salt.
Example 1
Arthrobacter CA-35 strain (FERM-P No. 5145; ATCC No. 31651) was cultivated as follows:
Composition of Culture Medium
Cholic acid 100 g
Ammonium nitrate 2.0 g
Potassium dihydrogen phosphate 2.0 g
Dipotassium hydrogen phosphate 5.0 g
Magnesium sulfate heptahydrate 0.2 g
Yeast extract 0.1 g
Sodium hydroxide 10 g
Distilled water to 1 liter
The above ingredients were admixed to obtain a culture medium (1 liter). Each 100 ml portion of the culture medium was distributed to ten Sakaguchi flasks (volume 500 ml) and autoclaved at 1 2O0C for 1 5 minutes. To each flask, there was added 10 ml portion of seed culture which was obtained by previously cultivating the strain in the same medium with shaking at 30 C for 2 days.Each flask was incubated on a shaker at 300C for 2 days.
After completion of cultivation, the culture broth was combined and centrifuged to remove microbial cells. The resulting supernatant was acidified by addition of 1 N aqueous hydrochloric acid (600 ml) to form a precipitate. the precipitate was separated and the remaining solution was extracted with ethyl acetate (1 liter). Ethyl acetate was distilled off from the extract by a rotary evaporator and the residue was combined with the above precipitate to obtain a mixture of cholanic acid derivatives and cholic acid (85 g).
A small portion of the mixture was dissolved in methanol in a concentration of 1%. The solution (10 l) was injected to a high-speed liquid chromatography apparatus equipped with a juBondapak C18 column (HLC-GPC-244 type produced by Waters in U.S.A.).
The column was eluted with water-methanol (30:70, v/v, pH 2.5) at the rate of 1 ml/min and refractive index of the eluate was measured.
The accompanying Figure 1 shows the resulting chromatogram. The peaks A, B, C and D in Figure 1 correspond to those of the reference standards of 7cL-hydroxy-3,1 2-diketo-SP-cholanic acid, 3a,7a- dihydroxy-12-keto-5/3-choíanic acid, 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
Further, when the compounds in the fractions corresponding to the peaks A, B and C were isolated and their chemical constitutions were determined based on the mass spectra, IR spectra and
NMR spectra thereof, these spectra showed that these compounds were 7α-hydroxy-3,12-diketo-5ss- cholanic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid and 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid, respectively. The accompanying Figures 2, 3 and 4 show the IR spectra (A, B and C) of methyl esters of the compounds corresponding to the peaks A, B and C in comparison with those of the reference standards (A', B' and C'), respectively.
The melting points of the compounds and methyl esters thereof corresponding to the peaks A, B and C are shown in Table 2.
Table 2
Melting Points of Melting Points of
the Methyl Esters the Free Acids ( CI (0C) Compounds Found Literature Found Literature
Peak A 150-152 152-154 Peak B 154-156 156-157 219-220 221-222 Peak C 168-169 169-172 185-186 186-188 The yield of the products and the amount of cholic acid which remained without being converted were calculated based on the area ratio of the chromatogram of Figure 1. The results are shown in
Table 3.
Table 3
Conversion Yield or
Compounds Area Ratio Rate(%) Amount (g) 7a-hydroxy-3,12- 28.54 28.54 24.3
diketo-5ss-cholanic
acid (peak A) 3a,7cg-dihydroxy-12- 63.06 63.06 53.6 keto-5p-cholanic acid (peak B) 7a,12a-dihydroxy- 1.54 1.54 1.30 3-keto-5p-cholanic acid (peak C)
Cholic acid (peak D) 6.86 6.86 5.80
Example 2
The same procedure as described in Example 1 was repeated except that the glucose (5.0 g/l was further added to the medium to obtain a mixture of products and cholic acid which remained without being converted (91.0 g). The mixture (91.0 g) was dissolved in methanol (270 ml) and added thereto conc. hydrochloric acid (9 ml).The resulting solution was heated under reflux for 20 minutes to convert the products and cholic acid into methyl esters thereof.
Silica gel C-200 (1500 g) was packed in a column (1200 mmx70 mm in diameter) and the above methyl esters were adsorbed thereto. The column was eluted with chloroform to obtain 7- hydroxy3,1 2-diketo-SP-cholanic acid methyl ester (25.1 g). Then, the column was eluted with chloroform-ethanol (99:1 v/v) to obtain, firstly,7cg,12c-dihydroxy-3-keto-5/,-cholanic acid methyl ester (1.40 g) and then 3a,7 a-dihydroxy-12-keto-5p-cholanic acid methyl ester (56.4 g).
These methyl esters were hydrolized to obtain 7α-hydroxy-3,12-diketo-5ss-cholanic acid (24.8 g), 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid (1.38 g) and 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid (56.0 g).
Example 3
The same procedure as described in Example 1 was repeated except that a concentration of cholic acid was varied and sodium hydroxide was added to a medium in an amount of 10% by weight based on cholic acid used. The yield of products and the amount of cholic acid which remained without being converted at each concentration of the substrate (cholic acid) are shown in Table 4.
Table 4
Yields
Substrate Concentration (girl) Compounds 50 200 300 3α, 7α-dihydroxy- 27.1 g 108.3g 47.4g 12-diketo-5ss-cholanic
acid 7a-hydroxy-3,12- 12.3 g 49.0 g 21.4g diketo-5ss-cholanic
acid 7a,12ce-dihydroxy- 0.7 g 2.65 g 1.20 g
3-keto-5ss-cholanic
acid Cholicacid small 20.1 g 230g
amount
Example 4
The same procedure as described in Example 2 was repeated except that each flask was incubated on a shaker at 300C for 24 hours to obtain a mixture of products and cholic acid which remained without being converted (98.0 g).The mixture was subjected to high-speed liquid chromatography under the same conditions as in Example 1 to determine the composition thereof. The results are shown in Table 5.
Table 5
Compounds Ratio 3α, 7α-hydroxy-12-keto-5ss-cholanic 67.7 7α-hydroxy-3,12-diketo-5ss-cholanic 8.3 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid 4.0
Cholic acid 20.0
Example 5
The same procedure as described in Example 2 was repeated except that 20 ml portion of seed culture obtained by cultivating at 30 C for 24 hours was added to each flask to obtain a mixture of products and cholic acid which remained without being converted (117.0 g). The mixture was subjected to high-speed chromatography under the same conditions as in Example 1 to determine the composition thereof. The results are shown in Table 6.
Table 6
Compounds Ratio 3alpha;, 7α-dihydroxy-12-keto-5ss-cholanic 63.3 7α-hydroxy-3,12-diketo-5ss-cholanic 23.5 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid 2.0
Cholic acid 11.2
Example 6
Arthrobacter CA-35-A589-29-32 strain (FERM-P No. 5521; ATCC No. 31 652) was cultivated as follows:
Composition of Culture Medium
Cholic acid 100 g
Ammonium nitrate 2.0 g
Potassium dihydrogen phosphate 2.0 g
Dipotassium hydrogen phosphate 5.0 g
Magnesium sulfate heptahydrate 0.2 g
Yeast extract 0.1 g
Sodium hydroxide lOg Glucose 5.0 g
Tap water to 1 liter
The above ingredients other than glucose were admixed in tap water to adjust the volume to 800 ml and autoclaved at 1 200C for 15 minutes.Glucose was dissolved in tap water (200 ml) and autoclaved at 1 1 OOC for 30 minutes. After cooling, both solutions were combined to obtain a culture medium (1 liter). Each 100 ml portion of the culture medium was distributed to ten Sakaguchi flasks (volume 500 ml) under aseptic conditions. To each flask, there was added 2 ml portion of seed culture which was obtained by previously cultivating the strain in the same medium with shaking at 300C for
14 hours. Each flask was incubated on a shaker at 300C for 3 days.
After completion of cultivation, the culture broth was combined and centrifuged to remove microbial cells. The resulting supernatant was acidified by addition of 1 N aqueous hydrochloric acid (600 ml) to form a precipitate. The precipitate was separated and the residual solution was extracted with ethyl acetate (1 liter). Ethyl acetate was distilled off from the extract by a rotary evaporator and the residue was combined with the above precipitate to obtain a mixture of cholanic acid derivatives and cholic acid (99.3 g).
A small portion of the mixture was dissolved in methanol in a concentration of 2%. The solution (10 l) was injected to a high-speed liquid chromatography apparatus equipped with a juBondapak C18 column (HLC-GPC-244 type).
The column was eluted with water-methanol (30:70, v/v), pH 4.0) at the rate of 1 ml/min and refractive index of the elute was measured.
The accompanying Figure 5 shows the resulting chromatogram. The peaks B and D in Figure 5 are corresponding to those of the reference standards of 3a,7a-dihydroxy-1 2-keto-5-cholanic acid and cholic acid, respectively.
When the compound in the fraction corresponding to the peak B was isolated and its chemical constitution was determined based on the mass spectrum, IR spectrum and NMR spectrum, these spectra showed that the compound was 3a,7cg-dihydroxy-12-keto-5p-cholanic acid.
The yield of the products and the amount of cholic acid which remained without being converted were calculated based on the area ratio of the chromatogram of Figure 5. The results are shown in
Table 7.
Table 7
Conversion* Yield or
Compounds Rate(%) Amount(g) 3zg,7-dihydroxy-12-keto-5,B- 98.85 98.16
cholanic acid (peak B)
Other derivatives 0.59 0.59
produced from cholic acid
Cholic acid (peak D) 0.56 0.55 *conversion rate was calculated based on the area ratio.
Example 7
The same procedure as described in Example 6 was repeated except that a microbial cells suspension which was prepared by separating microbial cells from the seed culture (10 ml) by centrifugation and suspending them in sterilized water (10 ml) was added to each flask instead of 2 ml of seed culture to obtain a mixture of products and remaining cholic acid (99.5 g). The mixture (99.5 g) was dissolved in methanol (270 ml) and added thereto conc. hydrochloric acid (9 ml). The resulting solution was heated under reflux for 20 minutes to convert the products and cholic acid into methyl esters thereof.
Silica gel C-2O0 (1500 g) was packed in a column (1200 mmx70 mm in diameter) and the above methyl esters were adsorbed thereto. The column was eluted with chloroform-ethanol (99:1, v/v) to obtain 3cr,7a-dihydroxy-l 2-keto-SP-cholanic acid methyl ester (102.0 g) which was hydrolyzed to obtain 3cr,7-dEhydroxy-12-keto-5ss-cholanic acid (98.5 g).
Example 8
The same procedure as described in Example 6 was repeated except that the concentration of cholic acid was varied, sodium hydroxide was added to a medium in an amount of 10% by weight based on cholic acid used and 1 N aqueous hydrochloric acid was added in an amount of 60 ml per 1 g of sodium hydroxide used to form a precipitate. The conversion rate or yield of the product and the amount of remaining cholic acid at each concentration of the substrate (cholic acid) are shown in Table 8.
Table 8
Conversion Rate or Yield
Substrate Concentration (girl) Compounds 1 5 10 20 50 100 200 3a,7-dihydroxy-12- 96.7%* 98.0%* 9.3 g 19.5 g 49.6 g 98.2 g 129.2 g
keto-5ss-cholanic
acid
Cholic acid 0.4% 0.7%* 0.1 g 0.2 g 0.1 g 0.6 g 70.0 g *conversion rate.
Example 9
The same procedure as described in Example 6 was repeated except thatArthrobacter CA-35
A589-47 strain (FERM-P No. 5523; ATCC No. 31653) was used instead ofArthrobacterCA-35-A589- 29-32 strain, the concentrations of cholic acid and sodium hydroxide in the medium were changed to 50 g/l and 5 g/l, respectively and each flask was incubated at 30 C for 35 hours to obtain a mixture of products and remaining cholic acid (49.31 g).
The mixture was subjected to same high-speed liquid chromatography under the same conditions as in Example 6.
The accompanying Figure 6 shows the resulting chromatogram. The peaks A, B, C and D in Figure
6 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3a,7a- dihydroxy-l 2-keto-SP-cholanic acid, 7αm 12alpha;-dihydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B, C and D were separated and subjected to thin layer chromatography, each fraction corresponding to the peak B, C or D contained a single compound. The fraction corresponding to the peak A was a mixture of 7a-hydrnxy-3,1 2-diketo-5- cholanic acid and another unidentified material.
The yield of the products and the amount of cholic acid which remained without being converted were calculated based on the area ratio of the chromatogram of Figure 6. the results are shown in
Table 9.
Table 9
Con version Yield or
Compounds Rate(%) Amount(g) 7 ct-hyd roxy3, 1 2-di keto-5P- 0.80 0.39
cholanic acid and unidentified
material (peak A) 3a,7ar-dihydrnxy-1 2-keto- 98.01 48.33
5ss-cholanic caid
(peak B) 7α, 12α-dihydroxy-3-keto- 5p-cholanic acid
(peak C)
Other derivatives 0.24 0.12
Cholic acid (peak D) 0.70 0.35
Example 10
The same procedure as described in Example 9 was repeated except thatArthrobacter CA-35
A849 strain (FERM-P No. 5524; ATCC No. 31654) was used instead ofArthrobacterCA-35-A589-47 strain to obtain a mixture of products and remaining cholic acid (49.34 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 7 shows the resulting chromatogram. The peaks A, B, C and D in Figure 7 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3a,7a- dihydroxy-1 2-keto-5-cholanic acid, 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B, C and D were separated and subjected to thin layer chromatography, each fraction contained a single compound.
The yield of the products and the amount of cholic acid which remained without being converted were calculated based on the area ratio of the chromatogram of Figure 7. The results are shown in
Table 10.
Table 10
Conversion . Yield of
Compounds Rate ( /0) Amount(g) 7 a-hyd roxy-3,1 2-di keto- 3.2 1.58
5ss-cholanic acid (peak A) 3a,7a-dihydroxy-1 2-keto- 83.5 41.20
5-cholanic acid
(peak B) 7a,1 2a-dihydrnxy-3-keto- 7.9 3.90 5p-cholanic acid
(peak C)
Other derivatives 2.8 1.38
Cholic acid (peak D) 2.6 1.28
Example 11
The same procedure as described in Example 9 was repeated exceptthatArthrobacterCA-35-A
1071-15 strain (FERM-P No. 5525;ATCC No.31655) was used instead of Arthrobacter CA-35-A589- 47 strain to obtain a mixture of products and remaining cholic acid (49.31 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 8 shows the resulting chromatogram. The peaks A, B, C and D in Figure 8 correspond to those of the reference standard of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3α, 7α-di hydroxy-12-keto-5ss-cholanic acid, 7α, 12α-dihydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B, C and D were separated and subjected to thin layer chromatography, each fraction corresponding to the peak B, C or D contained a single compound. The fraction corresponding to the paek A was a mixture of7α-hydroxy-3,12-diketo-5ss- cholanic acid and another unidentified material.
The yield of the products and the amount of remaining cholic acid were calculated based on the area ratio of the chromatogram of Figure 8. The results are shown in Table 11.
Table 11
Conversion Yield or
Compounds Rate(%) Amount(g) 7a-hydroxy-3,12-diketo- 5.2 2.56 5/3-cholanic acid and un
identified material
(peak A)
3 a,7a-dihydroxy-1 2-keto- 93.9 46.30 5p-cholanic acid
(peak B) 7α,12α-dihydoxy-3-keto- 0.2 0.10
5ss-cholanic acid
(peals C)
Other derivatives 0.2 0.10
Cholic acid 0.5 0.25
Example 12
The same procedure as described in Example 9 was repeated except thatArthrobacter CA-35-A
1448 strain (FERM-P No. 5526; ATCC No. 31656) was used instead of Arthrobacter CA-35-A589-47 strain to obtain a mixture of products and remaining cholic acid (49.30 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 9 shows the resulting chromatogram. The peaks A, B, C and D in Figure 9 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3a,7a- dihydroxy-1 2-keto-5-cholanic acid, 7α, 12α-hydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B, C and D were separated and subjected to thin layer chromatography, each fraction corresponding to the peak B, C or D contained a single compound. The fraction corresponding to the peak A was a mixture of 7α-hydroxy-3,12-diketo-5ss- cholanic acid and another unidentified material.
The yields of the products and the amount of cholic acid which remained without being converted were calculated based on the area ratio of the chromatogram of Figure 9. The results are shown in
Table 12.
Table 12
Conversion Yield or
Compounds Rate(%) Amount(g) 7α-hydroxy-3,12-diketo-5ss- 6.5 3.20
cholanic acid and unidentified
material (peak A) 3α, 7α-hydroxy-12-keto- 88.0 43.39 5p-cholanic acid
(peak B) 7a,1 2a-dihydroxy-3-keto- 0.3 0.15
5ss-cholanic acid
(peak C)
Other derivatives 0.1 0.05
Cholic acid (peak D) 5.1 2.51
Example 13
The same procedure as described in Example 9 was repeated exceptthatArthrobacterCA-35-A- 1475 strain (FERM-P No. 5527;ATCC No.31657) was used instead of Arthrobacter CA-35-A589-47 strain to obtain a mixture of products and cholic acid which remained without being converted (49.35 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 10 shows the resulting chromatogram. The peaks A, B, C and D in
Figure 10 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid, 7 ru,l 2n -dihydroxy-3-keto-51;-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B, C and D were separated and subjected to thin layer chromatography, each fraction contained a single compound.
The yield of the products and the amount of cholic acid were calculated based on the area ratio of the chromatogram of Figure 10. The results are shown in Table 13.
Table 13
Conversion Yield or
Compounds Rate (%) Amount 8g) 7-hydrnxy-3, 1 2-diketo-5- 3.26 1.61
cholanic acid (peak A) 3rx,7 α-dihydroxy-12-keto-5ss- 92.0 45.40
cholanic acid (peak B) 7α, 12α-dihydroxy-3-keto-5ss- 0.20 0.10
cholanic acid (peak C)
Other derivatives small amount
Cholic acid (peak D) 4.54 2.24
Example 14
The same procedure as described in Example 9 was repeated except thatArthrobacter CA-35-A
1766-15 strain (FERM-P No. 5528; ATCC No. 31 658) was used instead of Arthrobacter CA-35-A58947 strain to obtain a mixture of the products and cholic acid (49.27 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 11 shows the resulting chromatogram. The peaks A, B and D in Figure
11 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B and D were separated and subjected to thin layer chromatography, each fraction contained a single compound.
The yield of the products and the amount of remaining cholic acid were calculated based on the area ratio of the chromatogram of Figure 11. The results are shown in Table 14.
Table 14
Conversion Yield or
Compounds Rate(%) Amount(g) 7a:-hydroxy-3,12-diketo-5,B- 0.23 0.11
cholanic acid (peak A) 3α, 7α-dihydroxy-12-keto- 97.02 47.80 5p-cholanic acid (peak B)
Other derivatives 0.75 0.37
Cholic acid (peak D) 2.0 0.99
Example 15
The same procedure as described in Example 9 was repeated except thatArthrobacter CA-35-M
965-3 strain (FERM-P No. 5529; ATCC No. 31659) was used instead of Arthrobacter CA-3 5-A589-47 strain to obtain a mixture of products and cholic acid (49.36 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 12 shows the resulting chromatogram. The peaks A, B and D in Figure
12 correspond to those of the reference standards of 7 a-hydroxy3,1 2-diketo-SP-chol anic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peaks A, B and D were separated and subjected to thin
layer chromatography, each fraction corresponding to the peak B or D contained a single compound.
The fraction corresponding to the peak A was a mixture of 7α-hydroxy-3,12-diketo-5ss-cholanic acid
and another unidentified material.
The yield of the products and the amount of remaining cholic acid were calculated based on the
area ratio of the chromatogram of Figure 12. The results are shown in Table 1 5.
Table 15
Conversion Yield or
Compounds Rate(%) Amount(g) 7a-hydroxy-3,1 2-diketo-5k- 8.6 4.24
cholanic acid and unidentified
material (peak A) 3a,7a-dihydrnxy-1 2-keto- 85.3 42.11 5p-cholanic acid (peak B)
Other derivatives 2.0 0.99
Cholic acid (peak D 4.1 2.02
Example 16
The same procedure as described in Example 9 was repeated except thatArthrobacter CA-35-Y
37-12 strain (FERM-P No. 5530; ATCC No. 31660) was used instead of Arthrobacter CA-35-A589-47 strain to obtain a mixture of products and cholic acid (49.33 g).
The mixture was subjected to high-speed liquid chromatography under the same conditions as in
Example 6.
The accompanying Figure 13 shows the resulting chromatogram. The peaks A, B, C, and D in
Figure 13 correspond to those of the reference standards of 7a-hydroxy-3,12-diketo-5p-cholanic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid, 7α, 12α-7α-dihydroxy-3-keto-5ss-cholanic acid and cholic acid, respectively.
When the fractions corresponding to the peeks A, B, C and D were separated and subjected to thin layer chromatography, each fraction contained a single compound.
The yield of the products and the amount of remaining cholic acid were calculated based on the area ratio of the chromatogram of Figure 13. The results are shown in Table 1 6.
Table 16
Conversion Yield or
Compounds Rate(%) Amount(g) 7-hydroxy-3,12-diketo-5p- 7.7 3.80
cholanic acid (peak A) 3 a,7 a-dihydroxy- 1 2-keto- 90.0 44.40
5ss-cholanic acid (peak B) 7a,1 2a-dihydrnxy-3-keto- 0.3 0.15
5ss-cholanic acid (peak C)
Cholic acid (peak D) 2.0 0.98
Example 17
The same procedure as described in Example 1 was repeated except that Brevibacterium CA-6 strain (FERM-P No.5144; ATCC No.31661) was used instead ofArthrobacterCA-35 strain.
The resulting mixture of products and remaining cholic acid was subjected to high-speed liquid chromatography as in Example 1.
The accompanying Figure 14 shows the resulting chromatogram.
When the compounds in the fractions corresponding to the peaks E, A, B and D were isolated and their chemical constitutions were determined based on the mass spectra, IR spectra and NMR spectra thereof, these spectra showed that these compounds were 7-hydroxy-3,12-diketo-A4-cholenic acid, 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3a,7 a-dihydroxy-l 2-keto-SP-cholanic acid and cholic acid, respectively. The compounds in the fractions corresponding to the peaks X and Y were unidentified.
In the chromatogram of Figure 14, the area ratio of the peaks other than peaks X and Y (i.e. the area ratio E:A:B:D) is 12.2:22.2:44.9:20.7.
Example 18
The same procedure as described in Example 1 was repeated except that Corynebacterium CA53 strain (FERM-P No. 5532; ATCC No. 31 662) was used instead ofArthrobacter CA-35 strain to obtain a mixture of products and cholic acid (82 g).
The resulting mixture was subject to high-speed liquid chromatography under the same conditions as in Example 1 except that water-methanol (30:70, v/v), pH 4.0) was used, instead of water-methanol (30:70, v/v, pH 2.5) as an eluate.
The accompanying Figure 15 shows the resulting chromatogram. The peaks A, B, C and D in
Figure 1 5 correspond to those of the reference standards of 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid, 7α-hydroxy-3,12-diketo-5ss-cholanic \4-cholenic acid and chloic caid, respectively.
When the compounds in the fractions corresponding to the peaks A, B and C were isolated and their chemical constitutions were determined based on the mass spectra, IR spectra and NMR spectra thereof, these spectra showed that these compounds were 7α-hydroxy-3,12-diketo-5ss-cholanic acid, 7α-hydroxy-12-keto-5ss-cholanic acid and 7se-hydroxy-3,12-diketo- \4-cholenic acid, respectively.
Reference Example 1 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid (10 g) thus obtained was placed in a three-necked (round bottom) flask and slowly added thereto ethylene glycol (100 ml) and aqueous potassium hydroxide solution (potassium hydroxide 10 g+water 20 ml). Further 85% hydrazine hydrate (10 ml) was added and then, the resulting mixture was refluxed at 10 C for 2 hours. The temperature was gradually elevated and the reflux was continued at 185 to 1 900C for 4 hours to distill off hydrazine hydrate. After cooling, the reaction mixture was diluted with excess water and adjusted to pH 3 to fdrm a precipitate. The precipitate was collected by filtration, washed with water and air-dried to obtain 3,7cr-dihydroxy-5p-cholanic acid (CDCA), yield 8.5 g.
Reference Example 2
In a three-necked (round bottom) flask, 7α-hydroxy-3,12-diketo-5ss-cholanic acid (3 g) obtained in the above examples was dissolved in pyridine (70 ml) and added thereto tosyl chloride (1 mol). The resulting mixture was reacted at OOC for 1 hour and then, refluxed for 5 hours. After reflux, 3N aqueous hydrochloric acid was added and the reaction mixture was extracted with ether (100 ml). Ether was distilled off from the extract under a reduced pressure to give .\6- and/or \7-3,1 2-diketo-cholenic acid (2.5 g). The resultant (2 g) was dissolved in 1 N aqueous sodium hydroxide (10 ml) and added thereto
Raney nickel (0.1 g). After addition of hydrogen (0.01 mol), the mixture was reacted overnight to obtain 3(r,12(r-dihydroxy-5y3-cholanic acid (deoxycholic acid) and 3rF,1 2/;-dihydrOxy-5/j-cholanic acid (yield: 90%).
Claims (24)
1. A microbial process for producing a cholanic acid derivative of the formula:
wherein X is
or =0; and R is hydrogen, an alkali metal or an alkaline earth metal, which comprises cultivating a microbe which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce the cholanic acid derivative, selected from the genera Arthrobacter, Brevibacterium and
Corynebacterium, in a culture medium containing the substrate and collecting the resulting derivative.
2. A microbial process according to Claim 1, wherein the microbe is a member selected from the group consisting of Arothrobacter CA-35 strain (FERM-P No. 5145; ATCC No. 31651), Arthrobacter CA35-A589-29-32 strain (FERM-P No. 5522; ATCC No. 31652), Arthrobacter CA-35-A589-47 strain (FERM-P No. 5523; ATCC No.31653), ArthrobacterCA-35-A849 strain (FERM-P No. 5524; ATCC No.
31654), Arthrobacter CA-35-A-1 071-1 5 strain (FERM-P No. 5525; ATCC No. 31655), Arthrobacter
CA-35-A-1 448 strain (FERM-P No. 5526; ATCC No. 31 656),Arthrobacter CA-35-A-1 475 strain (FREM No. 5527; ATCC No. 31657). Arthrobacter CA-356-A-1766-15 strain (FERM No. 5288;
ATCC No.31 658),ArthrobacterCA-35-M-965-3 strain (FERM-P No. 5529; ATCC No.31659),
ArthrobacterCA-35-Y-37-12 strain (FERM-P No. 5530;ATCC No. 31660), Brevibacterium CA-6 strain (FERM-P No. 5144; ATCC No. 31661), and Corynebacterium CA-53 strain (FERM-P No. 5532; ATCC
No.31662).
3. A microbial process according to Claim 1, wherein the cholanic acid derivatives produced is 3α, 7α-dihydroxy-12-keto-5ss-cholanic acid.
4. A microbial process according to Claim 3, wherein the microbe is a member selected from the group consisting of Arthrobacter CA-35-A589-29-32 strain (FERM-P No. 5522; ATCC No.31652);
Arthrobacter CA-35-A589-47 strain (FERM-P No. 5523; ATCC No. 31653), Arthrobacter CA-35-A849 strain (FERM No. 5524; ATCC No. 31654), Arthrobaacter CA-35-A-1071-15 strain (FERM-P No.
5525; ATCC No. 31655), Arthrobacter CA-35-A-1448 strain (FERM-P No. 5526; ATCC No. 31656),
Arthrobacter CA-35-A-1475 strain (FERM-P No. 5527; ATCC No. 31657), Arthrobacter CA-35-A
1766-15 strain (FERM-P No. 5528; ATCC No. 31 658),Arthrobacter CA-35-M-965-3 strain (FERM-P No. 5529; ATCC No.31 659),ArthrobacterCA-35-Y-37-12 strain (FERM-P No. 5530; ATCC No.
31660).
5. A microbial process according to Claim 1 wherein the substrate is used in a concentration of 1 to 500 g/l as cholic acid.
6. A microbial process according to Claim 5, wherein the substrate is used in a concentration of 5 to 300 g/l as cholic acid.
7. A microbial process according to Claim 6, wherein the substrate is used in a concentration of
10 to 200 g/I as cholic acid.
8. Arthrobacter sp. which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce cholanic acid derivatives of the formula:
wherein X is
or =0; and R is hydrogen, an alkali metal or an alkaline earth metal.
9.Arthrobactersp. of Claim 8 beingArthrobacterCA-35 strain (FERM-P No.5145; ATCC No.
31651).
10. Arthrobacter sp. of Claim 8 being Arthrobacter CA-35-A589-29-32 strain (FERM-P No.
5522; ATCC No.31652).
11. Arthrobacter sp. of Claim 8 being ArthrobacterCA-35-A589-47 strain (FERM-P No. 5523;
ATCC No.31653).
12.Arthrobactersp. of Claim 8 beingArthrobacterCA-35-A849 strain (FERM-P No. 5524; ATCC
No.31654).
13. Arthrobacter sp. of Claim 8 being Arthrobacter CA-35-A-1071-1 5 strain (FERM-P No. 5525; ATCC No.31655).
14.Arthrobactersp. of Claim 8 beingArthrobacterCA-35-A-1448 strain (FERM-P No.5526;
ATCC No. 31656).
15.Arthrobactersp. of Claim 8 beingArthrobacterCA-35-A-1475 strain (FERM-P No.5527;
ATCC No.31657).
16. Arthrobacter sp. of Claim 8 being Arthrobacter CA-35-A-1 766-15 strain (FERM-P No. 5528; ATCC No. 31658).
1 7.Arthrobactersp. of Claim 8 beingArthrobacterCA-35-M-965-3 strain (FERM-P No. 5529; ATCC No.31659.).
18.Arthrobactersp. of Claim 8 beingArthrobacterCA-35-Y-37-12 strain (FERM-P No.5530;
ATCC No.31660).
19. Brevibacterium sp. which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce cholanic acid derivatives of the formula:
wherein X is
or =0; and R is hydrogen, an alkali metal or an alkaline earth metal.
20. Brevibacterium sp. of Claim 19 being Brevibacterium CA-6 strain (FERM-P No. 5144; ATCC
No.31661).
21. Corynebacterium sp. which is capable of growing in a medium containing cholic acid or a salt thereof as a substrate to produce cholanic acid derivatives of the formula:
wherein X is
or =0; and R is hydrogen, an alkali metal or an alkaline earth metal.
22. Corynebacterium sp. of Claim 21 being Corynebacterium CA-53 strain (FERM-P No. 5532; ATCC No. 31662).
23. A microbial process for producing a cholanic acid derivative substantially as hereinbefore
described in any one of the Examples.
24. A cholanic acid derivative of the formula
wherein X and R are as defined in Claim 1, prepared by a process as claimed in any one of Claims 1 to 7 or 23.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10676879A JPS5910197B2 (en) | 1979-08-21 | 1979-08-21 | Method for producing 3α,7α-dihydroxy-12-keto-5β-cholanic acid |
| JP11230779A JPS5910198B2 (en) | 1979-08-31 | 1979-08-31 | Method for producing 7α-hydroxy-3,12-diketo-5β-cholanic acid |
| JP12486679A JPS5951277B2 (en) | 1979-09-27 | 1979-09-27 | Novel microorganism |
| JP8225680A JPS578796A (en) | 1980-06-17 | 1980-06-17 | Preparation of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanic acid and/or its salt |
| JP8347880A JPS578795A (en) | 1980-06-19 | 1980-06-19 | Preparation of 3-substituted-7alpha-hydroxy-12-keto-5beta-cholanic acid and/or its salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2057447A true GB2057447A (en) | 1981-04-01 |
| GB2057447B GB2057447B (en) | 1984-01-25 |
Family
ID=27524962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8024436A Expired GB2057447B (en) | 1979-08-21 | 1980-07-25 | Microbal process for producing cholanic acid derivatives and microbes used therein |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH646442A5 (en) |
| DE (1) | DE3031334C2 (en) |
| FR (1) | FR2463809A1 (en) |
| GB (1) | GB2057447B (en) |
| IT (1) | IT1166482B (en) |
| NL (1) | NL185731C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0518661A1 (en) * | 1991-06-12 | 1992-12-16 | Tokyo Tanabe Company Limited | Microbial conversion of bile acids |
-
1980
- 1980-07-25 GB GB8024436A patent/GB2057447B/en not_active Expired
- 1980-08-20 CH CH628980A patent/CH646442A5/en not_active IP Right Cessation
- 1980-08-20 DE DE3031334A patent/DE3031334C2/en not_active Expired
- 1980-08-20 IT IT68301/80A patent/IT1166482B/en active
- 1980-08-21 NL NLAANVRAGE8004741,A patent/NL185731C/en not_active IP Right Cessation
- 1980-08-21 FR FR8018288A patent/FR2463809A1/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0518661A1 (en) * | 1991-06-12 | 1992-12-16 | Tokyo Tanabe Company Limited | Microbial conversion of bile acids |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2463809A1 (en) | 1981-02-27 |
| IT1166482B (en) | 1987-05-06 |
| CH646442A5 (en) | 1984-11-30 |
| IT8068301A0 (en) | 1980-08-20 |
| NL185731C (en) | 1990-07-02 |
| DE3031334A1 (en) | 1981-03-26 |
| NL185731B (en) | 1990-02-01 |
| FR2463809B1 (en) | 1983-09-09 |
| DE3031334C2 (en) | 1985-06-13 |
| NL8004741A (en) | 1981-02-24 |
| GB2057447B (en) | 1984-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001519654A (en) | Method for producing pravastatin sodium using Streptomyces exophoriatus YJ-118 and the above strain | |
| US5407826A (en) | Isolated cultures of microorganisms of Clonostachys Cylindrospora, Gliocladium and Nectria Gliocladioides | |
| US4359529A (en) | Microbial process for producing cholanic acid derivatives | |
| US5315038A (en) | Microorganism for breaking down moenomycins, a process for the breakdown, and the use of the breakdown products | |
| US4520102A (en) | Microbial process for producing 12α-hydroxypregna-1,4-dien-3-one-20α-carboxylic acid | |
| US5506140A (en) | Bacillus strain for breaking down moenomycins | |
| GB2057447A (en) | Microbial Process for Producing Cholanic Acid Derivatives and Microbes used Therein | |
| EP0187049B1 (en) | Micromonospora microorganisms and macrolide antibiotic production therewith | |
| KR100536676B1 (en) | A process for the biotransformation of colchicone compounds into the corresponding 3-glycosyl derivatives | |
| US4613571A (en) | Polyprenyl sulfone derivatives and process for producing the same | |
| AU655698B2 (en) | Process for producing optically active norborneol | |
| CA1169795A (en) | Microbial process for producing cholanic acid derivatives and microbes used therein | |
| GB2160866A (en) | Preparing 2-arylpropionic acids | |
| IE53238B1 (en) | Steroid transformation process | |
| EP0088007B1 (en) | Microbial process for producing 12-hydroxyandrosta-1,4-diene-3,17-dione | |
| US4923403A (en) | Microbiological process for degradation of steroids | |
| AU620595B2 (en) | Process for the preparation of macrolide compounds | |
| JPH0660170B2 (en) | Antibiotic preparation intermediate | |
| JPH0120873B2 (en) | ||
| HU183201B (en) | Microbiological process for preparing derivatives of cholanic acid | |
| JPH0262234B2 (en) | ||
| CA2212186A1 (en) | Novel bile acid-converting microorganism | |
| JPS6320519B2 (en) | ||
| JPH0523250B2 (en) | ||
| JPH0771480B2 (en) | New microorganism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE20 | Patent expired after termination of 20 years |
Effective date: 20000724 |